Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
$AACG
$ACRS
$ADIL
$ALLK
Other Consumer Services
Real Estate
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- Virax Biolabs Group Limited (NASDAQ:VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the European market.
- EUDA Health Holdings Limited (NASDAQ:EUDA) surged 53.1% to $2.94.
- Assure Holdings Corp. (NASDAQ:IONM) jumped 41.2% to $6.86.
- Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 36% to $1.69 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch Renazorb.
- WW International, Inc. (NASDAQ:WW) shares gained 29.8% to $5.02 despite worse-than-expected Q4 revenue and Q1 guidance below estimates. The company also announced it will acquire Weekend Health, Inc. for a net purchase price of $106 million.
- ThredUp Inc. (NASDAQ:TDUP) jumped 29% to $2.0892 after the company reported better-than-expected Q4 sales and issued strong Q1 guidance.
- Gaia, Inc. (NASDAQ:GAIA) gained 24% to $3.2588 following Q4 results.
- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) rose 21.3% to $0.51 after the company provided an update on its regulatory strategy for AD04. Adial will pursue paths towards US and Europe approvals and said market research suggests pricing could be more than double prior assumptions.
- Protagonist Therapeutics, Inc. (NASDAQ:PTGX) gained 20% to $18.25 after the company announced JNJ-2113 met its primary endpoint in the Phase 2b FRONTIER 1 clinical trial in psoriasis.
- Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 18.9% to $0.2069 after jumping around 35% on Monday.
- ATA Creativity Global (NASDAQ:AACG) shares rose 18.4% to $2.31. ATA Creativity, during November, posted a rise in quarterly sales.
- Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) jumped 17.4% to $3.24.
- Allakos Inc. (NASDAQ:ALLK) gained 17% to $6.32 following a narrower-than-expected quarterly loss.
- F-star Therapeutics, Inc. (NASDAQ:FSTX) gained 16.5% to $7.11. F-star Therapeutics announced CFIUS clearance for proposed acquisition by invoX Pharma.
- Anghami Inc. (NASDAQ:ANGH) gained 16.4% to $2.13.
- NeoGames S.A. (NASDAQ:NGMS) jumped 15.6% to $17.11 following upbeat quarterly earnings.
- Mercurity Fintech Holding Inc. (NASDAQ:MFH) gained 15.5% to $1.04.
- NeoGames S.A. (NASDAQ:NGMS) jumped 14.8% to $16.99 following strong quarterly earnings.
- Comstock Inc. (NYSE:LODE) gained 14.6% to $0.3526 after the company announced its metals recycling subsidiary will sell a facility for $27 million.
- Enfusion, Inc. (NASDAQ:ENFN) jumped 13.4% to $11.47 following strong sales.
- Sea Limited (NYSE:SE) shares gained 13.4% to $74.51 after the company reported better-than-expected Q4 revenues.
- Quotient Technology Inc. (NYSE:QUOT) jumped 12.4% to $3.73 after Reuters reported that the company is exploring a sale.
- Vivid Seats Inc. (NASDAQ:SEAT) rose 11.3% to $7.44 after the company reported Q4 financial results and issued guidance.
- Genelux Corporation (NASDAQ:GNLX) gained 10.5% to $5.02.
- Latham Group, Inc. (NASDAQ:SWIM) gained 10.2% to $3.7050 following Q4 results.
- Aclaris Therapeutics, Inc. (NASDAQ:ACRS) rose 9.6% to $7.75. Aclaris Therapeutics announced its Phase 2A study of Zunsemetinib for Hidradentis Suppurativa did not meet its primary or secondary endpoints.
- DICK'S Sporting Goods, Inc. (NYSE:DKS) gained 9% to $144.07 after the company reported better-than-expected Q4 results and issued strong FY23 guidance.
- ProKidney Corp. (NASDAQ:PROK) rose 8.2% to $12.90.
Losers
- Cara Therapeutics, Inc. (NASDAQ:CARA) shares dipped 29.9% to $7.03 after the company reported worse-than-expected Q4 results.
- Intrusion Inc. (NASDAQ:INTZ) fell 27.4% to $1.6257 after the company reported worse-than-expected Q4 results.
- Calavo Growers, Inc. (NASDAQ:CVGW) dipped 24.7% to $23.56 following weaker-than-expected Q1 results.
- Troika Media Group, Inc. (NASDAQ:TRKA) fell 21.6% to $0.6024. Troika Media Group reported revenue of $187.91 million for the six months ended FY22, up from $15.34 million a year ago.
- Ambrx Biopharma Inc. (NYSE:AMAM) shares dropped 20.9% to $9.91. Ambrx shares jumped 95% on Monday after the company announced its transfer from the NYSE to the Nasdaq.
- Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) dipped 20.8% to $0.4753.
- Freight Technologies, Inc. (NASDAQ:FRGT) fell 20.4% to $0.2389 after dropping more than 5% on Monday.
- Zynex, Inc. (NASDAQ:ZYXI) dropped 20.3% to $9.89 after the company announced it will postpone Q4 and FY22 financial results.
- ObsEva SA (NASDAQ:OBSV) fell 20% to $0.1597.
- Aris Water Solutions, Inc. (NYSE:ARIS) fell 19.6% to $10.65 after the company posted downbeat quarterly results.
- AerSale Corporation (NASDAQ:ASLE) dropped 17.2% to $16.81 following downbeat quarterly sales.
- Domo, Inc. (NASDAQ:DOMO) fell 16.3% to $13.77 following Q4 results.
- Biophytis S.A. (NASDAQ:BPTS) declined 15.6% to $0.5320.
- Zevra Therapeutics, Inc. (NASDAQ:ZVRA) fell 15% to $4.5450. Zevra Therapeutics posted a Q4 loss of $0.26 per share.
- Entera Bio Ltd. (NASDAQ:ENTX) shares fell 14.6% to $1.2250 after jumping 42% on Monday.
- Tremor International Ltd (NASDAQ:TRMR) fell 14.4% to $6.46 following 2022 results.
- BlackBerry Limited (NYSE:BB) fell 12.6% to $3.4850 after the company reported preliminary Q4 and FY23 results below estimates.
- Genesis Growth Tech Acquisition Corp. (NASDAQ:GGAA) dropped 10.8% to $11.08.
- Rivian Automotive, Inc. (NASDAQ:RIVN) fell 10.4% to $15.35. Rivian announced late on Monday that it intends to offer $1.3 billion worth of green convertible senior notes due 2029 in a private placement to qualified institutional buyers.
- Appreciate Holdings, Inc. (NASDAQ:SFR) fell 7.4% to $2.83 after jumping over 159% on Monday.
- Joby Aviation, Inc. (NASDAQ:JOBY) dropped 7.2% to $4.1750 after Deutsche Bank downgraded the stock from Hold to Sell and lowered its price target from $6 to $4.
- Nutanix, Inc. (NASDAQ:NTNX) fell 6.2% to $27.00 after the company reported preliminary second-quarter results and issued third-quarter guidance.
Now Read This: Insiders Selling Philip Morris International And 2 Other Stocks
